chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patient was 11 years old at the time of the vaccination. We discovered this on 6/10/2021. The patient's father told us on 5/20/2021 that she was born in 2008 and was 12 years old. We were unable to bill the insurance and we told him that he needed to fix the date of birth with the insurance company. At the second dose of the vaccine on 6/10/2021 we attempted to bill the insurance for the second dose of the vaccine and the date of birth was still flagged. We asked him about why that was not fixed and he said that it's because she is actually born in 2009, making her 11 years old. He later admitted that he just wanted his daughter to receive the vaccine. At this time we are not aware of a side effect or treatment being performed.
Fever.  Chills.  Headache.  Severe Joint Pain.   Started about 2am on Sunday 14 hours after injection Subsided in the morning and returned after lunch on Sunday.     Finally subsided Monday afternoon.
Case, reference number 1999020004 is a spontaneous report from a physician referring to a male patient, aged 35 years with follow up received from from the physician. The patient has no known drug allergies. He has a medical history allergic rhinitis, HTN, and tendonitis. At the time of the event, the pt was taking Relafen ( started 06/29/99), Prinivil 10mg (started in 06/97) and Claritin (started in 04/98). On 6/29/1999 th pt received the first injection of Havrix IM prior to traveling to Mexico. Approximately 3 weeks post vaccination, on 07/20/99, th pt developed neuropathy which included numbness on the back of the legs, leg pain and cramps, arthralgias, and diffuse pain. The pt was seen by his MD and treated with Relafen, prednisone, and flexeril and ambien. The most recent information received on 02/2000 reports the outcome of the events as ongoing, but not disabling.
Nausea; Vomiting; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea) and VOMITING (Vomiting) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea) and VOMITING (Vomiting). At the time of the report, NAUSEA (Nausea) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product was provided by the reporter. No treatment medication was provided.
pt recv vax 24FEB98 & 27FEB98 pt exp urticaria & was seen by MD;@ time of report the rash was getting worse;
Swollen right arm. Interior arm opposite to injection site red and swollen down to inside (toward body) elbow area.
Blood pressure drops severely when I stand up, resulting in at least 2 full blackouts and several near blackouts.
Swelling at injection site and surrounding area of upper arm that also included redness. Received one vaccine in each arm. Reaction was on left arm where ADACEL was injected.
I received Novavax vaccine as a booster because I had an adverse reaction to Moderna vaccines doses 1 and 2.  The reaction to Moderna dose 1 was extreme fatigue and a scratchy throat. The reaction to Moderna dose #2 was worse, with throat tightening and severe rash on the inside of the right arm. Severe stomach pains and shortness of breath.  The following symptoms were experienced within five minutes of receiving the Novavax shot: throat tightened and could not swallow. I experienced  shortness of breath, but my asthma was not triggered. I took a dose of 25mg of liquid Benadryl and the throat tightness and shortness of breath resolved. I was asked to sit near the pharmacy for thirty minutes (from 2 p.m. to 2:30 p.m. approximately)--I did not have a watch, so I am guesstimating on the time. My spouse drove me home after I had been at the pharmacy for thirty minutes and the pharmacist and I agreed that I was fine to go home. I did not have any other respiratory issues, but I have been experiencing stomach pains since I received the shot.  I also had an unusual menstrual cycle and experienced an unusual body odor after receiving the shot, which has since resolved.
COVID-19; COVID-19; This is a solicited report from a contactable consumer (patient) based on information received by Pfizer from (Control No: 21K-163-4088938-00). A 38-years-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 2 intramuscular on 15May2021 (at the age of 38-years-old) (Batch/Lot number was not reported) as DOSE 2, SINGLE, dose 1 intramuscular on 20Apr2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. HUMIRA, subcutaneous from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at unspecified dose for an unspecified indication. The patient's medical history and concomitant medications were not reported. The patient experienced covid-19 (Drug ineffective) (medically significant) on an unspecified date in Sep2021 with. The action taken in response to the events for HUMIRA was unknown. Outcome of events was unknown. The reporter's assessment of the causal relationship of the events with the suspect product bnt162b2 was reported as possible and causality of events with HUMIRA was not provided.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up. Based on known drug safety profile, there is reasonable possibility of causal association between the events Drug Ineffective and Suspected COVID-19 and the suspect drug bnt162b2 .
Patient became rigid, eyes rolled back in head, spaced out, appeared like a seizure, sweating profusely. Good Samaritan in line identified herself as a nurse and helped pharmacist keep patient's head still and taking pulse. Pharmacist got tech to call the clinic nurse who came over and took blood pressure and heart rate. Cold water bottles were placed behind patient's head and neck and nurses and pharmacist helped patient to the floor to get blood to his head. Tech called 911 and EMS reported to scene. EMS began to check patient's vitals and stood patient up only for patient to act like he was going to vomit and passed out again. EMS put patient on stretcher and took patient to a medical facility.
Vaccine was given at a different location.  Given at a Pharmacy.  We just gave aftercare for reaction.  Pt had rash all over body and fever.   Given Prednisone.  Still waiting to see recovery results.
PUFFY SORES; SWOLLEN JOINTS; This spontaneous report received from a consumer via a company representative concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced puffy sores, and swollen joints. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the puffy sores and swollen joints was not reported. This report was non-serious.
This case was reported in a literature article and described the occurrence of Miller Fisher syndrome in a 59-year-old male subject who was vaccinated with Influenza vaccine ((unspecified), manufacturer unspecified). This case corresponds to patient 4 in the literature article. On an unspecified date, the subject received an unspecified dose of Influenza vaccine (unspecified) (administration site and route unknown, batch number not provided). 2 weeks after vaccination with Influenza vaccine (unspecified), the subject experienced Miller Fisher syndrome, bilateral vertical and horizontal ophthalmoplegia, imbalance, ataxic gait, right ptosis, generalized areflexia, severe ataxia on finger-to-nose and heel-to-shin maneuvers, diplopia and absent vestibulo ocular reflex. The subject was hospitalised. Cerebrospinal fluid protein was 48 mg/dl. The electrodiagnostic findings on day 18 showed normal nerve conduction studies of the upper and lower extremities, facial nerve and blink reflexes. The subject was treated with normal immunoglobulin (IVIG). At the time of discharge, there was a slow improvement in eye movements, ataxia of gait and hands and persistent areflexia at the end of one week after IVIG. The outcome of the other events was unspecified. Summary of the literature article: Recent epidemiological studies established extremely rare incidence of Guillain-Barre syndrome after contemporary H1N1-influenza vaccine. The authors reported five subjects with 'atypical? GBS variants that started within four weeks of 2010/2011 H1N1-influenza vaccine. There was no evidence for other etiologies of GBS. The subjects presented with sensory ataxia, areflexia, extremity and oropharyngeal paresthesias, numbness, pain, weakness, sphincteric disturbances, and dysautonomia. One subject had Miller Fisher syndrome. All had elevated cerebrospinal fluid protein, and classic electrodiagnostic finding suggestive of GBS. All received the treatment with intravenous immunoglobulin with variable response. The author's conclusion stated that this series of subjects did not necessarily establish cause-effect relationship between the vaccination and the disease. They also emphasized that they couldn't draw general conclusion concerning the types of GBS after H1N1-influenza vaccine in larger populations. Epidemiological studies with large cohort were necessary to confirm excess cases of atypical GBS after H1N1-influenza vaccination. They also speculated the possibility that more "typical" cases of GBS after H1N1-influenza vaccine did not reach their attention at tertiary-care center but were treated by community neurologists. Nevertheless, the main message that we can draw from this study is that high index of suspicion and screening for atypical variant of GBS was warranted for the H1N1-influenza vaccinees who present with neuropathic manifestations within four weeks of vaccination.
WITHIN 24 HOURS OF TIME OF ADMINISTRATION, ONSET OF REDNESS LOCALIZED TO AREA OF INJECTION.  3cm X 3 cm, NONCIRCUMFERENTIAL.
Pt recvd vax 10NOV92 & immed exp burning & felt the vax going in; 17NOV92 pt exp pain in the arm which radiated into the shoulder; No further details were provided;
menstrual cycle started full week earlier than due; Administration date=06May2021, dose number=1/administration date=08Nov2021, dose number=2; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 08Nov2021 (Lot number: FG3527) at the age of 44 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Covid-19" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, single, Batch/Lot No: ew0176, Location of injection: Arm Left), administration date: 06May2021, when the patient was 43 years old, for Covid-19 Immunization. The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 08Nov2021, outcome "unknown", described as "Administration date=06May2021, dose number=1/administration date=08Nov2021, dose number=2"; POLYMENORRHOEA (non-serious) with onset 13Nov2021, outcome "recovering", described as "menstrual cycle started full week earlier than due". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of polymenorrhoea.  Additional Information :Patient had not received any other vaccines within 4 weeks before COVID vaccine and previously patient had diagnosed with COVID-19 POSITIVE and not tested for COVID-19 after the vaccination.  No follow-up attempts are possible. No further information is expected.
Information has been received from a physician referring to an unknown number of patients of unknown age and gender. Information regarding concomitant medication, medical history and drug reactions/allergies was not reported. On unknown dates, on or after 01-APR-2016, the patients were vaccinated with improperly stored doses of VARIVAX (lot # L024253 with expiration date 01-JUL-2017, lot # L024256 with expiration date 01-JUL-2017, lot # L001328 with expiration date 13-JAN-2017, lot # L016123 with expiration date 06-MAY-2017; dose and route were not reported). It was reported that the vaccine was improperly stored at 35.47 Fahrenheit for 314 hours and 15 minutes. There was no previous excursion and data logger was involved. No adverse effect was reported. This is one of two reports received from the same reporter. Follow up information has been received from the physician on 24-OCT-2016. On 24-OCT-2016, a call was placed to the physician. The call was received by another physician. The physician reported that she would have to research the request made for patient identifiers, lot number and expiration date and dates of vaccination. The correspondence details were reviewed with the physician, if information becomes available. Follow-up information was received on 09-NOV-2016 from an unspecified reporter, who provided the patient's demographics, and stated that the patient (of unknown age and gender) was vaccinated with an improperly stored dose of VARIVAX 0.5ml (unspecified dose) with lot # L024256 (expiration date 01-JUL-2017). No adverse experiences were reported. This is one of several reports received from the same reporter. Additional information is not expected, as follow ups requested to complete the case were received.
Injection site pain, arm pain from shoulder to elbow in injection arm full body aches throat pain headache/sinus pain jaw pain
Deep soreness in arm, that has lasted for over 2 months. Still sore, it hasn't healed or gone away yet.
Nausea, head ache, stress, drop in blood pressure, dizziness.  Lasted for a hour. Next day joint pain.  I got covid 19 In Jan. of 2022. I now have shortness of breath, tired, dizziness and head ache.
no additional AEs were provided; an expired PROQUAD (12/21/2021) was given to a patient on 12/29/2021; This spontaneous report has been received from a registered nurse referring to a patient of unknown age and gender. Concomitant medication, pertinent medical history, and drug reactions/allergies were not reported.  On 29-DEC-2021, the patient was vaccinated with expired Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live recombinant human albumin (rHA) (PROQUAD) 1 dose for prophylaxis (lot# T021643, expiration date 21-DEC-2021; strength and route were not reported) (expired product administered). No additional adverse events (AEs) or further information was provided.
10 hours after second dose I started feeling fever, chills, shivering, having to get up to pee every 45 minutes.  Symptoms got worse all night, additionally with nausea and vomiting.  Twice while sitting on the toilet holding barf bowl, I fainted, waking up finding myself lying on the floor.  Symptoms subsided 14 hours after they started.
Patient was given immunization that was expired on 6/14/23,.  Expired vaccine not pulled from fridge at time of given vaccine.
Patient said approximately 24 hours after receiving flu vaccine she developed hives that got worse over the course of the day. About 12 hours after developing hives patient passed out twice. 2 days after receiving the vaccine patient went to see PCP.
Carotid Artery Dissection; suspected it started on 5/18/21 with further tearing on 5/21/21. Additionally, on 5/25/21, my ability to swallow and speak was greatly diminished.  It was later determined on 6/3/21 that I had a carotid artery dissection and the dissection pushed on the nerves that controlled my voice box.
This spontaneous report was received from a physician via a company representative concerning a patient of unknown age and gender. On an unknown date (recently), the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiry date, dose and route unspecified). No concomitant medications were reported. On an unknown date, the patient broke out with shingles after the vaccination. On an unknown date, the patient sought medical attention (saw the healthcare professional). The outcome of the event was unknown. The relatedness for the event was unknown for ZOSTAVAX. Additional information has been requested.
30 minutes after receiving immunizations, patient stated she developed a difficulty swallowing and/or breathing. Patient BP & HR were normal when checked multiple times. Patient drank water as well. 1 hours after immunization patient stated she felt better and then suddenly mentioned that her throat felt like it was "ballooning up" with tightness again. Paramedics were called who also checked patient's vitals and confirmed all were optimal. It was recommended patient either take ambulance to hospital or go to ED herself. Patient declined. Paramedic had patient sign waiver that she declined further treatment. Patient was given a bottle of liquid benadryl and instructed to not take unless she felt the same problem again with breathing/swallowing and/or was at a safe location where she didn't have to drive. Patient had adolescent child with her to care for her. Patient stated she finally felt better and left.
Pt rec'd Pfizer COVID vaccine @1457. At 1522, Pt c/o feeling dizzy, heavy chest, and SOB". VS WNL. Reports Hx asthma, states current s/s "unlike asthma attacks which she gets every spring when the dogwood's bloom and which she feels in her throat". Takes daily Allegra which she did not take today. Reports Hx reaction to shingles vaccine with arm swelling and throat swelling. Has epi pen with her today. Pt monitored for 30 min post vaccination per risk assessment and 15 extra minutes. VS remained WNL and pt reported her SOB resolved and dizziness remained. States she "remembered she just started new doubled dose of duloxetine last night".
65 year old male recieved the 1st Dose of Pfizer COVID-19 Vaccine Lot# EN6200 on 03/01/2021 @ 11:30 and is scheduled for the second dose on 03/22/2021. Pt is a substitute teacher, was exposed on 03/16/2021 to a student who had cold-like symptoms and blew their nose multiple times. That evening on the 03/16/2021 pt started experiencing sore throat, but did not have a cough. Pt takes doxylamine (Unisom) and IBU to help sleep, and S-adenosyl-L-methionine (SAMe) supplement. Pt has sensitivity to gluten and denies being diagnosed with any medical conditions. Pt drank honey and tea for sore throat. Pt was advised to get a COVID test, if the test is (+) the pt should wait 90 days for the second dose and then would complete the vaccine treatment, and if the test is (-), the pt can receive the 2nd dose as scheduled. Pt was also advised to gargle with warm water + salt 2-3 times a day, and seek medical care/clinic/primary doctor for sore throat treatment. SPI was consulted and PCP was notified.
36 hours consisting of:  Headache, fever, vomiting, diarrhea , extreme fatigue
Fell and cut their left leg on their calf with rusty bob-wire; Got a tetanus shot; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FALL (Fell and cut their left leg on their calf with rusty bob-wire) and TETANUS IMMUNISATION (Got a tetanus shot) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included METFORMIN for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced FALL (Fell and cut their left leg on their calf with rusty bob-wire) and TETANUS IMMUNISATION (Got a tetanus shot). On 22-Mar-2021, TETANUS IMMUNISATION (Got a tetanus shot) outcome was unknown. At the time of the report, FALL (Fell and cut their left leg on their calf with rusty bob-wire) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information mentioned tetanus shot, bacitracin and keeping the area clean.  Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Fatigue, diarrhea first day.  Low-grade fever and injection sites soreness (both arms) the second day.
Local, reaction induration 4 1/2 " x 3 1/2"
She had previously received the Moderna covid vaccine on 3/29/21 unbeknownst to the vaccine provider.
Patient was given Moderna vaccine past BUD. Temperature excursion happened on 8/17/22.
Was in on 6/13/07 for Well Baby exam (4 months) and vaccines DTaP, IPV, Prevnar, ActHib, swelling and redness at injection site. Child had been crying and screaming since vaccines were given.
First on 4/5, and again on 4/8, patient reports blood coming from the "hole in my arm from the vaccine." It stopped after applying pressure. The arm was "really sore" initially after injection, but she did not not bleeding at the time of injection. She noted a scab had formed, but no rash. When bleeding started, she did not feel the scab had just been rubbed off. "There's only the hole there." She describes a very tiny hole, not a scar or sore. Among her chronic medications are a baby aspirin daily, and a generous dose of fish oil: 2,000mg BID.  Her last platelet count was 185,000 / uL on 2/11/21
Pt received Td and Pneumovax on 9/29/03. Presents today with inflammation, pain and erythema at site of injection (Pneumo) extending to elbow.
This case was reported by a healthcare professional and described the occurrence of antigenemia in an infant subject of unspecified gender who was vaccinated with Pediarix for prophylaxis. On an unspecified date the subject received unspecified dose of Pediarix (unknown). At an unspecified time after vaccination with Pediarix, the subject experienced antigenemia. Relevant test results included a positive hepatitis b surface antigen two days after Pediarix was given. At the time of reporting the outcome of the event was worse.
Within a day or so I started having vertigo and dizziness.  I had a second Moderna vaccination on 03/09/2021, and the booster Moderna vaccination on 08/30/2021, all at the Medical Center. All through the period since my first shot, I have had these symptoms.  These symptoms became especially bad right after the booster shot.  I feel light-headed, dizzy, unstable on my feet.  I have constant brain fog, and increased tinnitis.  I find these symptoms very disabling, leading to my inability to do most things that I have always done. I can only walk short distances, with a cane.  I can't spend much time cooking, and am unable to clean house, and can only tolerate short rides.  Even shopping is very difficult. I have become very depressed and experience anxiety.  In short, my whole life has been upended. My sleep has also been disrupted.  I had my flu shot sometime in September, I believe.  Also at the Med Center. I have also had several falls since the onset of this vertigo and dizziness.
Patient's previous 2 covid vaccines were manufactured by Moderna. Patient had marked Pfizer on paperwork.